Skip to main content
. 2017 May 4;8(39):64853–64866. doi: 10.18632/oncotarget.17614

Figure 6. CB2 agonist decreased oxidative stress levels in AD-MSCs subjected to H2O2/SD.

Figure 6

A. Flow cytometry analysis of ROS production in AD-MSCs after indicated treatment, n = 3. B. Quantitative analysis of A., C.-E. The SOD, GSH, and MDA level determined by respective commercially available assay kit. n = 3-6. *P < 0.05 between indicated groups.